Soleus Capital Master Fund, L.P. - Dec 31, 2024 Form SCHEDULE 13G/A Schedule Report for Terns Pharmaceuticals, Inc. (TERN)

Filing Manager
Soleus Capital Master Fund, L.P.
Reporting Manager
Soleus Capital Master Fund, L.P.
Security
Terns Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share
Symbol
TERN
Shares outstanding
84.8M shares
Disclosed Ownership
8.14M shares
Ownership
9.6%
Form type
SCHEDULE 13G/A
Date filed
2/11/2025, 04:00 PM
Date of event
Dec 31, 2024
SEC
View on sec.gov

Reporting Managers (6)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Soleus Capital Master Fund, L.P. 9.6% 8.14M 0 8.14M /s/ Guy Levy Guy Levy/Managing Member
Soleus Capital, LLC 9.6% 8.14M 0 8.14M /s/ Guy Levy Guy Levy/Managing Member
Soleus Capital Group, LLC 9.6% 8.14M 0 8.14M /s/ Guy Levy Guy Levy/Managing Member
Soleus Capital Management, L.P. 9.6% 8.14M 0 8.14M /s/ Guy Levy Guy Levy/Managing Member
Soleus GP LLC 9.6% 8.14M 0 8.14M /s/ Guy Levy Guy Levy/Managing Member
Guy Levy 9.6% 8.14M 0 8.14M /s/ Guy Levy Guy Levy